The CrickConnect team are delighted to be able to invite community members to join us for the institute's regular Crick Lecture.

Crick Lectures provide a broad insight into biomedical research from leading scientists. Not to be missed, the one-hour lectures are the event of the week for the Crick community to come together. 

Crick Lectures take place weekly (usually on Thursday at 16:00), and are given by leading scientists. The lectures aim to be accessible to scientists across different disciplines, while also offering something for the specialist.

Due to the pioneering and sensitive nature of some of the research discussed in these lectures, only Crick Lectures from selected speakers will be shared, and we ask all attendees to respect the private nature of these talks by refraining from making any type of recording, sharing access details or in any other way compromising the research that is discussed.

Principal Group Leader Luiz Pedro Carvalho will be giving this week's Crick Lecture, "A species-level strategy to reveal novel antibiotic resistance determinants"

There will also be a netwroking opportunity after the Lecture from 5pm. If you are able to join us in person at the Crick please let us know at connect@crick.ac.uk so we can arrange access

Luiz Pedro Carvalho

Luiz was born and grew up in the south of Brazil and obtained undergraduate (pharmacy) and MSc (cell and molecular biology) degrees from Federal University of Rio Grande do Sul. He moved to the USA to pursue his PhD studies in the laboratory of John S. Blanchard at the Biochemistry Department of the Albert Einstein College of Medicine in New York where he studied mechanistic enzymology, inhibition kinetics and protein chemistry.

Luiz joined Carl Nathan's laboratory at the Weill Cornell Medical College in New York for his post-doc ( 2006-2011), exploring the use of rational approaches to antibiotic research and studying Mycobacterium tuberculosis and its interaction with the host. 

In 2011 he came to London to establish his  Mycobacterial Metabolism and Antibiotic Research group at MRC-NIMR and from there moved to the Crick in 2015 where his research continues to focus on Mtb - working to understand at a cellular and molecular level how Mtb survives, causes disease, and develops resistance to antibiotics. The hope is that this research will lead to the development of new treatments for tuberculosis